Carson Michael J.
SEC insider (Form 3/4/5 filer). CIK 0001896079. Vice President, Finance at Nuvectis Pharma, Inc. (NVCT). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in FORT LEE, NJ.
Companies Carson Michael J. has filed insider reports for
- Nuvectis Pharma, Inc. (NVCT): Officer, Vice President, Finance
Carson Michael J.
CIK: 0001896079
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (16.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)5 (83.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVCT
Nuvectis Pharma, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 3, 2026NVCT
Nuvectis Pharma, Inc.
AwardDirect30K shares- - Jan 6, 2026NVCT
Nuvectis Pharma, Inc.
AwardDirect61.2K shares- - Jan 2, 2025NVCT
Nuvectis Pharma, Inc.
AwardDirect51K shares- - Nov 7, 2024NVCT
Nuvectis Pharma, Inc.
SaleDirect2.8K shares at avg. $8.16$22K - Jan 4, 2024NVCT
Nuvectis Pharma, Inc.
AwardDirect34.6K shares- - Jan 3, 2023NVCT
Nuvectis Pharma, Inc.
AwardDirect28.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 | NVCT Nuvectis Pharma, Inc. | Award | 30,000 | - | $0 | Direct |
| Jan 6, 2026 | NVCT Nuvectis Pharma, Inc. | Award | 61,200 | - | $0 | Direct |
| Jan 2, 2025 | NVCT Nuvectis Pharma, Inc. | Award | 51,000 | - | $0 | Direct |
| Nov 7, 2024 | NVCT Nuvectis Pharma, Inc. | Sale | 2,755 | $8.16 | $22,478 | Direct |
| Jan 4, 2024 | NVCT Nuvectis Pharma, Inc. | Award | 34,567 | - | $0 | Direct |
| Jan 3, 2023 | NVCT Nuvectis Pharma, Inc. | Award | 28,806 | - | $0 | Direct |
1-6 of 6 transactions